查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853365

神經病學病患監測市場依產品類型、監護模式、應用、最終用戶、組件、部署模式、連接方式和技術分類－2025-2032年全球預測

Neurology Patient Monitoring Market by Product Type, Monitoring Mode, Application, End User, Component, Deployment Mode, Connectivity, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經病學病患監測市場規模將達到 104.9 億美元，複合年成長率為 8.28%。

關鍵市場統計數據
基準年2024年 55.5億美元
預計年份：2025年 60億美元
預測年份 2032 104.9億美元
複合年成長率（%） 8.28%

全面說明神經病學病患監測領域，重點關注臨床促進因素、技術融合以及相關人員的關鍵決策因素。

隨著臨床需求與技術創新以及醫療服務模式的轉變，神經病學病患監測領域正迅速發展。本文首先闡述了推動投資和應用的關鍵臨床因素，包括持續、準確的神經系統數據對於改善從急性到慢性疾病的治療效果的重要性。此外，本文還概述了感測技術、訊號處理和軟體分析的融合如何重新定義臨床醫生和看護者可用的即時監護方式。

在此背景下，相關人員必須了解設備模式、監控模式和護理環境之間的相互作用，以便為採購和部署決策提供基礎。這一格局受到日趨成熟的醫院基礎設施、家庭和門診護理模式、監管機構對資料完整性和網路安全的嚴格審查以及日益成長的互通性期望的影響。儘早了解這些因素，能夠為讀者評估未來幾年將決定競爭優勢和臨床價值的技術、夥伴關係和能力奠定實際的基礎。

感測技術、人工智慧主導的分析以及混合護理模式的快速發展如何重塑神經監測領域的臨床工作流程、監管預期和競爭格局？

神經病學病患監測領域正經歷著一場變革性的轉變，這場轉變正在加速臨床應用，並重新定義競爭格局。感測器精度和訊號採集技術的進步帶來了前所未有的洞察，而邊緣運算和雲端分析則實現了更快的解讀和更及時的預警。同時，人工智慧融入解讀流程，透過標記異常情況、確定病例優先順序和縮短干預時間，增強了臨床醫生的工作流程，並將價值從原始數據收集轉移到智慧的、情境感知的決策支援。

除了技術進步之外，醫療服務模式也從依賴病患監測轉向融合門診、家庭和醫院環境的混合模式。這種轉變需要更強大的連接架構、更靈活的部署方案以及以患者為中心的設備人體工學設計。法律規範也在不斷發展，以應對醫療設備、資料隱私和上市後監管等問題，從而影響產品設計、檢驗策略和商業化路徑。因此，隨著這些變革力量的匯聚，那些能夠將產品創新與臨床工作流程、監管前瞻性和可擴展的支援模式相結合的機構，將獲得更大的臨床相關性和營運優勢。

檢驗2025年關稅政策的變化將如何推動供應鏈重組、採購多元化和策略採購轉變，進而影響神經監測操作。

美國關稅將於2025年實施，預計將在神經系統疾病病患監測生態系統中引發一系列營運和策略調整。進口零件和成品關稅導致的成本變化可能會影響籌資策略，促使供應商重新評估其供應鏈佈局，並考慮近岸外包和替代採購方式。隨著各機構的調整，採購週期和供應商談判可能會延長，從而影響設備的供應和臨床應用速度。

除了直接的成本影響外，關稅還可能促使供應商進行更廣泛的整合，並推動可製造性設計，從而強調組件標準化和模組化架構。此類應對措施可能會促使設備製造商和製造外包之間加強合作，以實現本地化生產或重新設計產品，以減輕關稅的影響。同時，醫療機構和系統可能會調整其供應商選擇標準，優先考慮那些擁有穩健供應鏈和明確應對方案的供應商。從中長期來看，關稅政策的累積影響將受到企業應對措施、外匯走勢以及成本壓力與維持不間斷神經監測能力的臨床需求之間不斷變化的平衡的影響。

層級細分分析能夠解讀產品模式、監測模式、臨床應用、最終用戶環境、組件、部署選項、連接方式以及推動產品普及的技術方向。

透過細緻的市場區隔，我們可以發現創新和應用集中在哪些領域，以及哪些需求仍未被滿足。就產品類型而言，腦電圖 (EEG)、肌電圖 (EMG)、顱內壓監測系統和經顱都卜勒設備各自具有不同的臨床應用場景、檢驗路徑和整合要求，這就要求供應商調整其價值提案，以滿足急性重症加護和長期門診評估的不同需求。在監測模式方面，包括 EEG、EMG 和經顱都卜勒在內的非侵入性技術在門診、睡眠和神經科科診所具有廣泛的應用前景，而磁腦圖和顱內壓監測等侵入性解決方案則可為重症加護決策提供更高保真度的訊號。

癲癇監測需要高時間解析度和偽影抑制，神經退化性疾病監測強調縱向資料收集和患者舒適度，睡眠障礙監測需要居家友善、非侵入式設計，而中風監測則優先考慮快速檢測並與急性護理路徑整合。最終使用者細分揭示了門診中心、居家照護機構和醫院不同的採購週期和支援需求，每種機構都對人員配備、基礎設施和報銷等方面提出了特定的限制。組件細分區分了硬體、服務和軟體收益源，凸顯了軟體主導的分析和售後臨床支援日益成長的重要性。雲端基礎和本地部署解決方案之間的部署差異影響著資料管治、延遲和規模的考量，而有線連接與無線連接的選擇則決定了安裝的複雜性、移動性和患者體驗。最後，人工智慧系統和傳統方法之間的技術差異凸顯了不同的開發重點：傳統系統則強調確定性演算法和經過認證的訊號處理流程。將這些細分觀點結合起來，可以更深入地了解臨床價值的實現點、採用障礙的差異以及策略性投資在哪些方面能帶來最大的回報。

全球醫療保健系統、監管框架和數位化準備程度的地域差異將如何影響優先事項、商業化和在地化策略

區域動態造就了不同的需求訊號和監管環境，進而影響產品策略、夥伴關係和商業化計畫。在美洲，臨床應用通常與優先考慮重症加護和研究的綜合醫療系統和學術醫療中心一致，同時，受價值醫療和遠距病患管理舉措的驅動，人們對家庭監測的興趣也在迅速成長。在歐洲、中東和非洲，報銷框架和醫療基礎設施的差異造成了異質性格局，臨床需求與成本控制之間的平衡必須根據各國的監管環境進行調整。

在亞太地區，醫療基礎設施投資的加速成長、對本土製造能力的重視以及患者群體的快速擴張，都催生了對可擴展、具成本效益監測解決方案的強勁需求。每個地區的數位化醫療發展現狀、網路安全期望以及臨床醫務人員能力各不相同，這些因素共同影響產品在地化需求、通路策略和服務模式。因此，有意拓展業務的公司必須根據每個地區的具體情況，調整其監管規劃、臨床證據產生和營運支援策略。

本文探討了產品傳承、軟體差異化、策略夥伴關係以及售後支援如何決定神經監測領域的競爭優勢和市場接受度。

神經病學病患監測領域的競爭格局正由傳統設備專長、新興軟體能力以及連接臨床、技術和服務能力的策略聯盟共同塑造。成熟的設備製造商擁有豐富的臨床檢驗經驗和分銷網路，推動著醫院層面的應用；而新參與企業和科技公司則憑藉軟體定義產品、人工智慧和以用戶為中心的設計脫穎而出。設備製造商、臨床研究機構和雲端平台供應商之間的夥伴關係正在加速證據產生和部署的規模化，從而創造出協作模式往往優於純粹內部成長策略的環境。

此外，能夠清楚展現售後臨床支援、培訓項目以及實際應用檢驗的公司，將優先獲得採購決策者的青睞。對監管事務、品質系統和網路安全管治的投入，也使值得信賴的供應商與發展尚不成熟的企業區分開來。因此，能夠有效整合經過驗證的感測硬體、強大的訊號處理能力以及透明且經臨床檢驗的分析技術，並透過可擴展的服務框架交付的企業，將擁有競爭優勢。這種多維度的產品和市場執行策略，對於在複雜的醫療保健環境中獲得持續發展至關重要。

指南領導力如何協調產品模組化、臨床檢驗、部署靈活性和彈性採購以確保長期應用和營運彈性的指南

行業領導者應採取策略，協調產品開發、監管規劃和商業性執行，以確保臨床相關性和營運永續性。優先考慮模組化產品架構，實現組件重複使用和快速迭代，從而減輕供應鏈中斷和關稅帶來的成本壓力。同時，投資強大的資料管治、網路安全和臨床檢驗項目，以支援人工智慧功能，並確保可解釋性和臨床醫生的信任。這些投資將有助於跨司法管轄區的解決方案認證，並協助滿足醫院的IT和合規要求。

在商業性領域，我們為醫院、門診和家庭環境推行靈活的部署和定價模式，並強調提供整合硬體、軟體和服務的捆綁式解決方案，以簡化採購流程並展現後續護理的益處。為了累積長期證據並加速指南的採納，我們優先發展能夠快速擴展培訓和技術援助的管道和支援基礎設施，並建立策略性的臨床夥伴關係關係。最後，我們積極主動地維護供應鏈和籌資策略，包括多元化的供應商、盡可能選擇區域性生產方式以及遵循設計原則，從而在市場環境變化的情況下保護利潤並確保醫療服務的連續性。

一種以證據主導的方法，結合了初步的臨床參與、二次技術審查和結構化的分析方法，為決策者提供可操作的資訊。

本研究結合了與臨床醫生、醫療系統採購負責人和產品主管的定性訪談，並輔以對監管申報文件、臨床文獻和公開技術文件的二次分析，旨在構建神經病學病患監測技術及其應用動態的整體情況。研究綜合了主要資訊，以捕捉工作流程整合、臨床優先事項和採購決策標準方面的經驗性見解，而二次資訊則提供了技術背景，並支持對設備功能和監管考慮進行三角驗證。

分析方法包括技術比較評估、情境分析（用於評估政策和供應鏈事件的影響）以及細分市場映射（用於識別產品類型、監測模式、應用、最終用戶、組件、部署模式、連接選項和技術方法等方面的未滿足需求）。在整個檢驗臨床醫生的經驗，並確保關於採納促進因素、監管里程碑和營運限制等假設的透明度。因此，該調查方法融合了實踐者觀點和結構化分析方法，旨在為決策者提供可操作的資訊。

本文簡要概述了將創新轉化為臨床影響的策略要務，重點關注互通性、證據生成、營運韌性和以臨床醫生為中心的設計。

總之，由於技術成熟、醫療服務模式演變以及供應鏈動態變化，神經病學病患監測領域正處於曲折點。能夠整合高保真感測技術、可解釋分析和靈活部署方案的機構，將更有能力滿足醫院、門診中心和居家照護機構的多樣化需求。同樣重要的是，這些機構還需具備應對複雜監管環境、透過真實世界證據證明臨床價值以及在政策和經濟逆風中保持穩健的供應鏈和生產策略的能力。

相關人員在規劃下一步行動時，應重點關注互通性、以臨床醫生為中心的設計以及上市後性能監測，以確保臨床應用的持續性和患者獲益。透過協調產品開發、證據產生和商業性執行，領導者可以將技術前景轉化為可衡量的臨床影響和持久的組織優勢。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合人工智慧驅動的預測分析平台，用於早期偵測神經系統事件
  • 推出一款穿戴式腦電圖感測器系統，可實現對癲癇發作的連續遠端監測。
  • 擴展雲端基礎的遠端監控網路，以支援神經病學患者即時數據分析。
  • 非侵入性顱內壓監測設備在水腦症早期診斷的應用
  • 採用標準化資料框架以提高神經監測系統之間的互通性
  • 開發人工智慧睡眠和運動追蹤工具，用於全面的神經退化護理
  • 整合行動應用程式介面以增強慢性神經系統疾病管理中的患者自我監測

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 神經病學病患監測市場（依產品類型分類）

  • 腦電圖
  • 肌電圖
  • ICP監測系統
  • TCD設備

9. 按監測模式分類的神經病學病患監測市場

  • 侵入性
    • 腦電皮質記錄
    • ICP監測
  • 非侵入性
    • 腦電圖
    • 肌電圖
    • TCD

第10章 按應用分類的神經病學病患監測市場

  • 癲癇監測
  • 神經退化性疾病監測
  • 睡眠障礙監測
  • 中風監測

第11章 神經病學病患監測市場（按最終用戶分類）

  • 門診治療中心
  • 居家照護環境
  • 醫院

第12章 神經病學病患監測市場（按組件分類）

  • 硬體
  • 服務
  • 軟體

第13章 依部署模式分類的神經病學病患監測市場

  • 雲端基礎
  • 本地部署

第14章 神經病學病患監測市場：連結性與性別

  • 有線
  • 無線的

第15章 神經病學病患監測市場（依技術分類）

  • 人工智慧
  • 傳統的

第16章 神經病學病患監測市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第17章 神經病學病患監測市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第18章 各國神經病學病患監測市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第19章 競爭情勢

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Koninklijke Philips NV
    • GE HealthCare Technologies Inc.
    • Nihon Kohden Corporation
    • Natus Medical Incorporated
    • Dragerwerk AG & Co. KGaA
    • Masimo Corporation
    • Medtronic plc
    • Compumedics Limited
    • Cadwell Laboratories, Inc.
    • Ceribell, Inc.
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market is projected to grow by USD 10.49 billion at a CAGR of 8.28% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.55 billion
Estimated Year [2025] USD 6.00 billion
Forecast Year [2032] USD 10.49 billion
CAGR (%) 8.28%

A comprehensive orientation to the neurology patient monitoring landscape that clarifies clinical drivers, technological convergence, and critical decision levers for stakeholders

The neurology patient monitoring domain is undergoing rapid evolution as clinical demand intersects with technological innovation and shifting care delivery paradigms. This introduction sets the stage by clarifying the clinical imperatives driving investment and adoption, including the need for continuous, accurate neurological data to improve outcomes across acute and chronic conditions. It also outlines how convergence among sensing technologies, signal processing, and software-enabled analytics is redefining what real-time monitoring can deliver for clinicians and caregivers.

Against this backdrop, stakeholders must understand the interplay of device modalities, monitoring modes, and care environments that shape procurement and deployment decisions. The landscape is influenced by hospital infrastructure, the maturation of home and ambulatory care models, regulatory scrutiny of data integrity and cybersecurity, and growing expectations for interoperability. By framing these forces early, readers gain a practical foundation for evaluating technologies, partnerships, and capabilities that will determine competitive differentiation and clinical value in the coming years.

How rapid advances in sensing, AI-driven analytics, and hybrid care models are reshaping clinical workflows, regulatory expectations, and competitive moats in neurology monitoring

The neurology patient monitoring space is experiencing transformative shifts that are accelerating clinical adoption and redefining competitive dynamics. Advancements in sensor fidelity and signal acquisition are enabling previously unobtainable insights, while edge processing and cloud-enabled analytics allow for faster interpretation and actionable alerts. Simultaneously, the integration of artificial intelligence into interpretation pipelines is augmenting clinician workflows by flagging anomalies, prioritizing cases, and reducing time to intervention, thus shifting the locus of value from raw data capture to intelligent, context-aware decision support.

In addition to technological progress, care-delivery models are shifting away from exclusive reliance on inpatient monitoring toward hybridized approaches that blend ambulatory, home-based, and hospital settings. This transition requires more robust connectivity architectures, flexible deployment options, and an emphasis on patient-centric device ergonomics. Regulatory frameworks are also evolving to address software as a medical device, data privacy, and post-market surveillance, which in turn influences product design, validation strategies, and commercialization pathways. Consequently, organizations that align product innovation with clinical workflows, regulatory foresight, and scalable support models will capture greater clinical relevance and operational traction as these transformative forces converge.

Examining how tariff policy changes in 2025 can prompt supply chain reconfiguration, sourcing diversification, and strategic procurement shifts affecting neurology monitoring operations

The introduction of United States tariffs in 2025 has potential to create a cascade of operational and strategic adjustments across the neurology patient monitoring ecosystem. Tariff-driven cost changes for imported components and finished devices can influence procurement strategies, prompting suppliers to reassess supply chain footprints and to explore near-shoring or alternative sourcing. As organizations adapt, procurement timelines and vendor negotiations may extend, which could affect device availability and the pacing of deployments in clinical settings.

Beyond immediate cost implications, tariffs can catalyze broader supplier rationalization and design-for-manufacturability efforts that emphasize component standardization and modular architectures. These responses may spur greater collaboration between device manufacturers and contract manufacturers to localize production or redesign products to reduce tariff exposure. At the same time, providers and health systems might prioritize vendors with resilient supply chains and clear mitigation plans, thereby reshaping vendor selection criteria. Over the medium term, the cumulative effects of tariff policy will be mediated by corporate responses, currency movements, and the evolving balance between cost pressures and the clinical imperative to maintain uninterrupted neurologic monitoring capabilities.

A layered segmentation analysis that deciphers product modalities, monitoring modes, clinical applications, end-use environments, components, deployment options, connectivity, and technology vectors driving adoption

A nuanced segmentation lens illuminates where innovation and adoption are concentrated and where unmet needs persist. When considering product categories, electroencephalography (EEG), electromyography (EMG), intracranial pressure monitoring systems, and transcranial Doppler devices each carry distinct clinical use cases, validation pathways, and integration requirements, and vendors must tailor value propositions to the differential needs of acute neuro-critical care versus longitudinal ambulatory assessment. In terms of monitoring mode, invasive solutions such as electrocorticography and intracranial pressure monitoring offer high-fidelity signals for critical care decision making, while non invasive techniques including EEG, EMG, and transcranial Doppler provide broader applicability across outpatient, sleep, and neurology clinic contexts, creating complementary adoption curves and differing requirements for clinician training and regulatory clearance.

Application-focused segmentation further refines opportunity areas, with epilepsy monitoring demanding high temporal resolution and artifact rejection; neurodegenerative disease monitoring emphasizing longitudinal data capture and patient comfort; sleep disorder monitoring requiring home-friendly, minimally obtrusive designs; and stroke monitoring prioritizing rapid detection and integration with acute care pathways. End-user distinctions reveal distinct procurement cycles and support needs across ambulatory care centers, home care settings, and hospitals, each of which imposes specific constraints related to staffing, infrastructure, and reimbursement. Component segmentation separates hardware, services, and software revenue streams and underscores the rising importance of software-driven analytics and post-sale clinical support. Deployment mode differences between cloud-based and on-premise solutions shape data governance, latency, and scale considerations, while connectivity choices between wired and wireless determine installation complexity, mobility, and patient experience. Finally, technology differentiation between AI-enabled systems and traditional approaches highlights divergent development priorities: AI-enabled offerings require robust training datasets, explainability, and post-market performance monitoring, whereas traditional systems focus on deterministic algorithms and certified signal processing pipelines. Taken together, these segmentation perspectives enable a layered understanding of where clinical value is realized, how adoption barriers vary, and where strategic investments will yield the greatest returns.

How geographic differences in healthcare systems, regulatory frameworks, and digital readiness shape prioritization, commercialization, and localization strategies across global regions

Regional dynamics create differentiated demand signals and regulatory contexts that influence product strategy, partnerships, and commercialization plans. In the Americas, clinical adoption often aligns with integrated health systems and academic medical centers that prioritize advanced monitoring for critical care and research, alongside a rapidly growing interest in home-based monitoring driven by value-based care and remote patient management initiatives. Across Europe, Middle East & Africa, variations in reimbursement frameworks and healthcare infrastructure result in a heterogeneous landscape where clinical needs are balanced against cost containment imperatives, and where local regulatory pathways necessitate tailored evidence generation and distribution strategies.

In the Asia-Pacific region, accelerating investment in healthcare infrastructure, a strong emphasis on domestic manufacturing capability, and rapidly expanding patient populations are creating vigorous demand for scalable, cost-effective monitoring solutions. Each of these regional contexts also differs in digital health readiness, cybersecurity expectations, and clinical workforce capacity, which collectively shape product localization requirements, channel strategies, and service models. Therefore, firms seeking to expand their footprint must align regulatory planning, clinical evidence generation, and operational support with the distinct priorities and constraints present within each geographic region.

Insights into how product heritage, software differentiation, strategic partnerships, and post-sale support determine competitive advantage and adoption trajectories in neurology monitoring

Competitive dynamics in the neurology patient monitoring space are being defined by a combination of legacy device expertise, emergent software capabilities, and strategic alliances that bridge clinical, technological, and services competencies. Established device manufacturers contribute deep clinical validation experience and distribution networks that facilitate hospital-level adoption, while newer entrants and technology firms are differentiating through software-defined offerings, artificial intelligence, and user-centric design. Partnerships between device makers, clinical research entities, and cloud-platform providers are enabling accelerated evidence generation and deployment scalability, creating an environment where collaborative models often outpace purely organic growth strategies.

Moreover, companies that demonstrate clear post-sale clinical support, training programs, and evidence of real-world performance are gaining preferential access to procurement decision makers. Investment in regulatory affairs, quality systems, and cybersecurity governance further distinguishes credible suppliers from less mature players. As a result, competitive advantage accrues to organizations that can effectively combine validated sensing hardware, robust signal processing, and transparent, clinically validated analytics delivered through scalable service frameworks. This multi-dimensional approach to product and market execution is increasingly essential for achieving sustained traction in complex healthcare environments.

Action-oriented guidance for leaders to align product modularity, clinical validation, deployment flexibility, and resilient sourcing to secure long-term adoption and operational resilience

Industry leaders should pursue a coordinated strategy that aligns product development, regulatory planning, and commercial execution to capture clinical relevance and operational sustainability. Prioritize modular product architectures that enable component reuse and rapid iteration, thereby reducing exposure to supply chain disruptions and tariff-driven cost pressures. Simultaneously, invest in robust data governance, cybersecurity, and clinical validation programs that support AI-enabled functionality while ensuring explainability and clinician trust. These investments will make it easier to certify solutions across jurisdictions and to satisfy hospital IT and compliance requirements.

In the commercial realm, cultivate flexible deployment and pricing models that accommodate hospital, ambulatory, and home-based settings; emphasize bundled offerings that integrate hardware, software, and services to simplify procurement and to demonstrate downstream care benefits. Forge strategic clinical partnerships to build longitudinal evidence and to accelerate guideline adoption, and prioritize channels and support infrastructures that can rapidly scale training and technical assistance. Finally, maintain a proactive supply chain and sourcing strategy that includes diversified suppliers, regional manufacturing options where feasible, and design-for-manufacture principles to preserve margin and ensure continuity of care delivery as market conditions evolve.

An evidence-driven methodology combining primary clinical engagement, secondary technical review, and structured analytical approaches to produce actionable intelligence for decision makers

This research integrates primary qualitative engagements with clinicians, health system procurement leaders, and product executives, supplemented by secondary analysis of regulatory filings, clinical literature, and publicly available technical documentation to construct a holistic view of neurology patient monitoring technologies and adoption dynamics. Primary inputs were synthesized to capture experiential insights on workflow integration, clinical priorities, and procurement decision criteria, while secondary sources provided technical context and supported triangulation of device capabilities and regulatory considerations.

Analytical methods included comparative technology assessment, scenario analysis to evaluate the implications of policy and supply chain events, and segmentation mapping to identify unmet needs across product types, monitoring modes, applications, end users, components, deployment models, connectivity options, and technology approaches. Throughout the analysis, emphasis was placed on validation against clinician experience and on the transparency of assumptions related to adoption drivers, regulatory milestones, and operational constraints. The methodology therefore blends practitioner-informed perspectives with structured analytical techniques to provide actionable intelligence for decision makers.

A succinct synthesis of strategic imperatives emphasizing interoperability, evidence generation, resilient operations, and clinician-centered design to translate innovation into clinical impact

In conclusion, the neurology patient monitoring landscape is at an inflection point driven by technological maturation, evolving care delivery models, and shifting supply chain dynamics. Organizations that integrate high-fidelity sensing, explainable analytics, and flexible deployment options will be best positioned to meet the diverse needs of hospitals, ambulatory centers, and home care environments. Equally important is the ability to navigate regulatory complexity, to demonstrate clinical value through real-world evidence, and to maintain resilient supply and manufacturing strategies in the face of policy and economic headwinds.

As stakeholders plan next steps, they should focus on interoperability, clinician-centric design, and post-market performance monitoring to ensure sustained clinical adoption and patient benefit. By aligning product development, evidence generation, and commercial execution, leaders can convert technological promise into measurable clinical impact and durable organizational advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven predictive analytics platforms for early neurological event detection
  • 5.2. Deployment of wearable EEG sensor systems enabling continuous remote seizure monitoring
  • 5.3. Expansion of cloud-based telemonitoring networks to support real-time neurology patient data analytics
  • 5.4. Emergence of non-invasive intracranial pressure monitoring devices for early diagnosis of hydrocephalus
  • 5.5. Adoption of standardized data frameworks to enhance interoperability across neurology monitoring systems
  • 5.6. Development of AI-enabled sleep and movement tracking tools for comprehensive neurodegenerative care
  • 5.7. Integration of mobile application interfaces to empower patient self-monitoring in chronic neurological management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Patient Monitoring Market, by Product Type

  • 8.1. EEG
  • 8.2. EMG
  • 8.3. ICP Monitoring System
  • 8.4. TCD Device

9. Neurology Patient Monitoring Market, by Monitoring Mode

  • 9.1. Invasive
    • 9.1.1. Electrocorticography
    • 9.1.2. ICP Monitoring
  • 9.2. Non Invasive
    • 9.2.1. EEG
    • 9.2.2. EMG
    • 9.2.3. TCD

10. Neurology Patient Monitoring Market, by Application

  • 10.1. Epilepsy Monitoring
  • 10.2. Neurodegenerative Disease Monitoring
  • 10.3. Sleep Disorder Monitoring
  • 10.4. Stroke Monitoring

11. Neurology Patient Monitoring Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals

12. Neurology Patient Monitoring Market, by Component

  • 12.1. Hardware
  • 12.2. Services
  • 12.3. Software

13. Neurology Patient Monitoring Market, by Deployment Mode

  • 13.1. Cloud Based
  • 13.2. On Premise

14. Neurology Patient Monitoring Market, by Connectivity

  • 14.1. Wired
  • 14.2. Wireless

15. Neurology Patient Monitoring Market, by Technology

  • 15.1. AI Enabled
  • 15.2. Traditional

16. Neurology Patient Monitoring Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. Neurology Patient Monitoring Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Neurology Patient Monitoring Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. Competitive Landscape

  • 19.1. Market Share Analysis, 2024
  • 19.2. FPNV Positioning Matrix, 2024
  • 19.3. Competitive Analysis
    • 19.3.1. Koninklijke Philips N.V.
    • 19.3.2. GE HealthCare Technologies Inc.
    • 19.3.3. Nihon Kohden Corporation
    • 19.3.4. Natus Medical Incorporated
    • 19.3.5. Dragerwerk AG & Co. KGaA
    • 19.3.6. Masimo Corporation
    • 19.3.7. Medtronic plc
    • 19.3.8. Compumedics Limited
    • 19.3.9. Cadwell Laboratories, Inc.
    • 19.3.10. Ceribell, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 34. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 35. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 36. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROLOGY PATIENT MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (US